Moreover, two cancer-associated pathways, the NF-κB signaling pathway and the JAK-STAT signaling pathway, were also hyperactivated in the H subtype (Supplementary Fig. 2a), suggesting that the activities of these two tumor signaling pathways are associated with SKCM immunity. This evidence concerns the gene NFKB1 and cancer.